May pag-asa! COVID-19 vaccine from Pfizer & BioNTech shows potential in human trial

May pag-asa! COVID-19 vaccine from Pfizer & BioNTech shows potential in human trial

- A COVID-19 vaccine being developed by Pfizer and BioNTech reportedly showed encouraging results

- The scientists found out that those who received the potential vaccine generated antibodies against the coronavirus

- However, double or higher doses had side effects including fever

- The Pfizer still has to conduct larger studies to prove if the vaccine could give immunity against COVID-19

PAY ATTENTION: Click "See First" under the "Following" tab to see KAMI news on your News Feed

It has been reported that the vaccine being created by pharmaceutical giant Pfizer and biotech firm BioNTech showed positive results in early study.

KAMI learned that the COVID-19 vaccine being developed has shown potential in human trial.

May pag-asa! COVID-19 vaccine from Pfizer & BioNTech shows potential in human trial

Photo from Getty Images
Source: Facebook

In a report by the Reuters (authored by Ludwig Burger and Patricia Weiss), the potential vaccine is the fourth early-stage COVID-19 vaccine that showed promising results in human testing.

The researchers discovered that the vaccine generated antibodies against the coronavirus in all of the 45 patients by 28 days after receiving a single injection.

"These preliminary data are encouraging, showing that BNT162b1 which exploits RBD SARS-CoV-2 as a target antigen is able to produce neutralizing antibody responses in humans at or above the levels observed in convalescent sera – and that it does so at relatively low dose levels. We look forward to providing further data updates on BNT162b1," Dr. Ugur Sahin, CEO and co-founder of BioNTech said.

However, double or higher doses of the said potential vaccine caused fever and other side effects. It is also not yet proven if higher antibody levels will give immunity against the coronavirus.

As reported by CNBC (authored by Matthew Herper), in order to prove the immunity, Pfizer needs to conduct larger studies that aims to show that 50% of the people who received the vaccine will not be infected.

PAY ATTENTION: Enjoyed reading our story? Download KAMI's news app on Google Play now and stay up-to-date with major Filipino news!

According to the World Health Organization (WHO), there are currently 17 coronavirus disease vaccines that are being developed and in clinical evaluation across the globe.

WHO director-general Tedros Adhanom Ghebreyesus claimed that an “effective” vaccine for COVID-19 is still uncertain for now.

Meanwhile, scientists claimed that the first “life-saving” medicine against the COVID-19 has been found.

Please like and share our Facebook posts to support KAMI team! Don’t hesitate to comment and share your opinion about our stories either. We love reading about your thoughts!

Source: Kami.com.ph

Mailfire view pixel